MEF2B Instructs Germinal Center Development and Acts as an Oncogene in B Cell Lymphomagenesis.
MEF2B Instructs Germinal Center Development and Acts as an Oncogene in B Cell Lymphomagenesis.
复制标题
DOI:
10.1016/j.ccell.2018.08.006
复制
发表时间:
2018-09-10
期刊:
影响因子:
50.3
通讯作者:
Dalla-Favera R
中科院分区:
文献类型:
--
作者:
Brescia P;Schneider C;Holmes AB;Shen Q;Hussein S;Pasqualucci L;Basso K;Dalla-Favera R
The gene encoding the MEF2B transcription factor is mutated in germinal-center (GC)-derived B-cell lymphomas, but its role in GC development and lymphomagenesis is unknown. We demonstrate that Mef2b deletion reduces GC formation in mice and identify MEF2B transcriptional targets in GC, with roles in cell proliferation, apoptosis, GC confinement and differentiation. The most common lymphoma-associated MEF2B mutant (MEF2BD83V) is hypomorphic, yet escapes binding and negative regulation by components of the HUCA complex and class IIa HDACs. Mef2bD83V expression in mice leads to GC enlargement and lymphoma development, a phenotype that becomes fully penetrant in combination with BCL2 de-regulation, an event associated with human MEF2B mutations. These results identify MEF2B as a critical GC regulator and a driver oncogene in lymphomagenesis. MEF2B is mutated in ~15% of Follicular Lymphoma and Diffuse Large B cell Lymphoma, the most common types of mature B cell malignancies. Here we establish a critical physiologic role of MEF2B in the development of GC B cells, the cell-of-origin of most human B cell lymphomas. Modeling the expression of the most frequent lymphoma-associated MEF2B mutant allele in mice, we demonstrate that mutant MEF2B contributes to lymphomagenesis in vivo and identify the involved biochemical mechanism. MEF2B mutant-driven mouse lymphomas represent a faithful model of the human disease for pre-clinical therapeutic testing. Brescia et al. show that MEF2B is critical for germinal center (GC) formation and identify MEF2B transcriptional targets in GC B cells. They also characterize the most common lymphoma-associated MEF2B mutant (MEF2BD83V) and demonstrate that MEF2BD83V leads to GC enlargement and lymphoma development in mice.
登录
查看更多内容
影响因子:
64.8
作者:
Ernst, Jason;Kheradpour, Pouya;Mikkelsen, Tarjei S.;Shoresh, Noam;Ward, Lucas D.;Epstein, Charles B.;Zhang, Xiaolan;Wang, Li;Issner, Robbyn;Coyne, Michael;Ku, Manching;Durham, Timothy;Kellis, Manolis;Bernstein, Bradley E.
通讯作者:
Bernstein, Bradley E.
DOI:
10.1093/bioinformatics/btu638
发表时间:
2015-01-15
期刊:
Bioinformatics (Oxford, England)
影响因子:
--
作者:
Anders S;Pyl PT;Huber W
通讯作者:
Huber W
影响因子:
5.3
作者:
Banumathy, Gowrishankar;Somaiah, Neeta;Adams, Peter D.
通讯作者:
Adams, Peter D.
影响因子:
4.8
作者:
Fischle, W;Emiliani, S;Verdin, E
通讯作者:
Verdin, E
影响因子:
14.8
作者:
Blecher-Gonen, Ronnie;Barnett-Itzhaki, Zohar;Amit, Ido
通讯作者:
Amit, Ido